The Journey from Laboratory to Life-Changing Treatment

Every medication you take, every treatment that brings you relief, started as an idea tested in a clinical trial. Real patients, facing real challenges just like yours, chose to participate in research, and their courage created the treatments that help millions today.

This month, we want to show you the incredible impact clinical research has made in rheumatology, and how participating in trials today could shape the future of care for generations to come.

Story 1: Biologics for Rheumatoid Arthritis – A Revolution in Care: From Trial to Treatment: 1998 to Today

In the late 1990s, rheumatoid arthritis treatment was limited to medications that often provided minimal relief and came with significant side effects. Then came the first biologic medication trials, testing a completely new approach that targeted specific parts of the immune system rather than suppressing it entirely.

Early trial participants took a leap of faith. They didn’t know if these medications would work, but they knew the current options weren’t enough. Their participation led to FDA approval of the first biologic for RA in 1998.

The Impact Today:

  • Biologics have transformed RA from a potentially crippling disease to a manageable condition for millions
  • Patients can maintain active lifestyles, continue working, and avoid joint damage
  • The success of RA biologics paved the way for biologic treatments for psoriatic arthritis, ankylosing spondylitis, and other autoimmune conditions

Real Patient Impact: “Before biologics, I couldn’t open a jar or tie my shoes. Now I garden, play with my grandchildren, and live without constant pain. I’m grateful every day to the people who participated in those early trials.” – Katie,S. Current OAOC patient

Story 2: Gout Medications – From Limited Options to Real Control: From Trial to Treatment: 2008-2015

For decades, gout patients had very few medication options, and many couldn’t tolerate the side effects or achieve adequate uric acid control. When new medications entered clinical trials in the late 2000s, participants with difficult-to-treat gout volunteered, hoping for better options. Their participation led to FDA approval of several new gout medications that work differently from older treatments, offering hope to patients who had run out of options.

The Impact Today:

  • Patients who couldn’t tolerate older medications now have alternatives
  • More people can achieve target uric acid levels and prevent flares
  • Newer medications offer more flexible dosing and fewer dietary restrictions
  • People with gout can enjoy better food freedom and quality of life

Real Patient Impact: “I used to have 4-5 gout attacks a year that sent me to the ER. Since starting one of these newer medications that came from clinical trials, I haven’t had a single flare in two years. I can travel without fear, enjoy meals with my family, and live my life.” – Peter,K. -OAOC Gout Clinic patient

Story 3: Osteoporosis Treatments – Building Stronger Bones: From Trial to Treatment: 1995 to Today

Osteoporosis was once considered an inevitable part of aging, with limited treatment options. Clinical trials tested new medications that could actually build bone density rather than just slow bone loss. Trial participants, many postmenopausal women at high risk for fractures, contributed to research that revolutionized bone health care.

The Impact Today:

  • Multiple medication classes now available to strengthen bones
  • Significant reduction in hip and spine fractures among treated patients
  • Better quality of life and independence for older adults
  • Combination approaches that address bone health from multiple angles

Your Opportunity to Shape Tomorrow’s Treatments: Right now, at OAOC and Lakeside Clinical Research, we’re conducting studies that could become the next breakthrough treatment. We’re actively enrolling patients for studies in:

  • Gout – Testing new approaches to dissolve lumps of uric acid and prevent future attacks.
  • Psoriatic Arthritis – Investigating treatments that target both joint and skin symptoms.
  • Polymyalgia Rheumatica – Exploring alternatives to long-term steroid use.

What Trial Participation Offers You:

  • Access to Innovation: New treatments before they’re widely available, potentially offering relief when standard treatments haven’t worked
  • Enhanced Medical Care: More frequent visits, detailed assessments, comprehensive monitoring throughout the study
  • Expert Attention: Specialized care from experienced rheumatologists and dedicated research coordinators who focus intensely on your outcomes and wellbeing
  • Financial Relief: No cost for study-related visits, tests, and medications. Most studies also provide compensation for your time and travel expenses
  • Making a Difference: Your participation directly contributes to treatments that will help future patients manage these conditions better

Ready to Learn More? If you have gout, psoriatic arthritis, or polymyalgia rheumatica and are interested in exploring whether clinical research might be right for you, we’d love to hear from you.

📧 Email: study@overlakearthritis.com 📞 Call/Text: (425) 307-6459 ext 116 🌐 Visit: www.oaocresearchcenter.com

Individual results may vary, and participation in any clinical trial is completely voluntary. You’ll receive detailed information about any study before deciding whether to participate.